Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Coherus Oncology (CHRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
9 analysts
Options Flow (P/C)
—
Avg Consensus PT
$7
+587.9%
Highest Price Target
$12
+1059.4%
Lowest Price Target
$1
+1.4%
Short Interest
15.6%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Guggenheim | Paul Jeng— | +866.2% | $12 → $10 | Maintained | Buy |
| May 11, 2026 | Guggenheim | —— | +1059.4% | $12 | Initiate | Buy |